FibroGen (FGEN) EV/EBITDA US GAAP (year values)

2020 2021 2021 2022 2023   LTM ? CAGR 5 years ?
EV/EBITDA ? -16.3 -3.63 -3.45 -4.13 -0.08   0.74  
Changes by years, y/y, % -74% -78% -5% +19% -98%     -71.7%

FibroGen. EV/EBITDA

FibroGen. EV/EBITDA, changes, %

FibroGen (FGEN) EV/EBITDA US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
EV/EBITDA ? 0.05 -0.08 -1.03 -0.78 0.89   0.74
Changes by years, y/y, % -102% -98% -79% +187% +1 799%    
Changes by quarters, q/q, % -117% -279% +1 129% -25% -215%    

FibroGen. EV/EBITDA

FibroGen. EV/EBITDA, changes, y/y, %

FibroGen. EV/EBITDA, changes, q/q, %